Valeria Paradies

Temporal Trends in Coronary Physiology Testing and Intravascular Imaging Adoption in Poland (2014–2025)

Michał Hawranek, Artur Dziewierz, Marta Kałużna‐Oleksy, Mariusz Tomaniak et autres

BACKGROUND: Intravascular ultrasound (IVUS), optical coherence tomography (OCT), and fractional flow reserve (FFR) improve percutaneous coronary intervention (PCI) outcomes. However, their adoption varies globally due to clinical, economic, and healthcare policy factors. OBJECTIVES: To analyze temporal trends in coronary physiology testing and …

pl, gb, nl (code pays fourni par la source)

Intravascular Lithotripsy in Diabetic Patients Undergoing Percutaneous Coronary Intervention: Long-Term Outcomes from the BENELUX Registry

Akshay A S Phagu, Federico Oliveri, Brian O. Bingen, Valeria Paradies et autres

Diabetes mellitus (DM) is associated with increased coronary calcification and adverse outcomes after percutaneous coronary intervention (PCI), yet the performance of intravascular lithotripsy (IVL) in this high-risk population remains insufficiently defined. This study, conducted within the all-comers BENELUX-IVL registry, evaluated the safety …

nl, it, be, gr (code pays fourni par la source)

Early oral anticoagulation monotherapy after PCI: Insights from the POEM trial

Carlo Andrea Pivato, Gianluca Mincione, Leon Gramss, Andrea Pacchioni et autres

BACKGROUND: In high-bleeding-risk (HBR) patients undergoing percutaneous coronary intervention (PCI), shortening dual antiplatelet therapy (DAPT) is essential, but the optimal approach in those requiring oral anticoagulation (OAC) is uncertain. We evaluated a 1-month dual antithrombotic regimen in HBR patients with and without …

it, nl (code pays fourni par la source)

Drug-Coated Balloon After Intravascular Lithotripsy

Federico Oliveri, Akshay A S Phagu, Ibtihal Al Amri, Brian O. Bingen et autres

BACKGROUND: Drug-eluting stents (DESs) after intravascular lithotripsy (IVL) have proven effective in calcified coronary lesions. However, evidence supporting drug-coated balloons (DCBs) after IVL remains limited. OBJECTIVES: We aimed to compare the technical success and 1-year clinical outcomes of IVL + DES vs …

nl, it, be (code pays fourni par la source)

19 Drug coated balloons versus drug-eluting stents in patients with de novo coronary artery disease: a systematic review and meta-analysis of randomised controlled trials

Dermot S. O’Callaghan, H Rai, Daniele Giacoppo, J J Coughlan et autres

Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. This meta-analysis compared the efficacy and safety …

ie, au, nl, es (code pays fourni par la source)

TCT-651 The EAPCI Device Success Algorithm Prospectively Adjudicated by Imaging Core Lab in the PIONEER IV Trial: Insights with Angiography-Derived FFR

TsungYing Tsai, Asahi Oshima, Joanna J. Wykrzykowska, Liesbeth Rosseel et autres

ie, nl, gb, be, es (code pays fourni par la source)

TCT-155 Ultrathin- vs Thin- struts stent in calcified coronary lesion: A multicenter retrospective study

Gianluca Mincione, Eleni Ntantou, Wijnand K. den Dekker, Joost Daemen et autres

it, nl (code pays fourni par la source)

TCT-522 Clinical and angiographic features of a wide population of native coronary artery disease treated with stent or sirolimus-coated balloon. The TRANSFORM II BASIC randomized clinical trial

Bernardo Cortese, Mohsin Ahmed, Fazila‐Tun‐Nesa Malik, Valeria Paradies et autres

us, bd, nl, es, br, it, fr, gb, pl, bn, sg, pt (code pays fourni par la source)

Incidence of Complications Following Coronary Intravascular Lithotripsy, Clinical Outcomes, and Predictors of Complications

Akshay A S Phagu, Federico Oliveri, Brian O. Bingen, Valeria Paradies et autres

Background: This study aimed to evaluate the incidence of complications associated with intravascular lithotripsy (IVL) therapy, assess clinical outcomes, and identify predictors of complications in a real-world patient cohort. Methods: Patients undergoing IVL between May 2019 and September 2024 were enrolled from …

nl, be (code pays fourni par la source)

Coronary microvascular dysfunction: Focus on pathophysiological mechanisms and recent diagnostic techniques

Gianluca Mincione, Matteo Maurina, Alice Benedetti, Mauro Chiarito et autres

it, be, nl (code pays fourni par la source)

Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis

Valeria Paradies, Giulia Masiero, Andrea Rubboli, Heleen M.M. van Beusekom et autres

Thrombotic and bleeding risks differ between sexes, partly in relation to distinct biology and hormonal status, but also due to differences in age, comorbidities, and body size at presentation. Women experience frequent fluctuations of prothrombotic and bleeding status related to menstrual cycle, …

nl, it, es, ch, gb, pt, sa, de, pl, us, at (code pays fourni par la source)

Coronary microvascular dysfunction: Phenotype-specific targeted therapies

Gianluca Mincione, Matteo Maurina, Alice Benedetti, Mauro Chiarito et autres

it, be, nl (code pays fourni par la source)